Medidata Champions Collaborative Scientific Advancement at ASCO with New Research on Oncology Protocol Optimization and CAR T Efficacy
Leveraging AI, trained on one of the industry’s largest clinical trial datasets, Medidata delivers quantifiable evidence to improve breast cancer trial enrollment and evaluate the efficacy of tocilizumab for CAR T-induced CRS NEW YORK, May 29, 2026 (GLOBE NEWSWIRE) — Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life […]
Original Source
Read the full article at Financialpost →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.